Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Takeda Pharmaceutical Co Ltd (TAK) since 2026 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Takeda Pharmaceutical Co Ltd. Table 2 shows the detailed insider transactions. This company's CIK number is 1395064.
Total stock buying since 2026: $0.
Total stock sales since 2026: $9,817,177.
Total stock option exercises since 2026: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2026 | 0 | $0 | 572,753 | $9,817,177 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2026-08 | 0 | $0 | 572,753 | $9,817,177 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-08-11 | Shannon Elaine Mary (Pres., Global Supply & Quality) | Sale | 20,363 | 17.55 | 357,370 |
| 2026-08-10 | Greenway Nicola Deidre Petal (Chief Human Resources Officer) | Sale | 41,377 | 17.30 | 721,491 |
| 2026-08-10 | Ibrahim Ramy Riad Ahmed (President, PDT BU) | Sale | 7,277 | 17.10 | 124,436 |
| 2026-08-10 | Farajallah Awny Samaan Botros (Chief Medical Officer) | Sale | 14,006 | 17.10 | 239,502 |
| 2026-08-10 | Furney Natalie Anne Marie (Global General Counsel) | Sale | 30,868 | 17.10 | 527,842 |
| 2026-08-10 | Pacheco Rhonda Janice (President, U.S. Business Unit) | Sale | 16,901 | 17.10 | 289,007 |
| 2026-08-10 | Shannon Elaine Mary (Pres., Global Supply & Quality) | Sale | 3,978 | 17.10 | 68,023 |
| 2026-08-10 | Pignagnoli Agosti Marcello (Head, Strat. & Port. Dev) | Sale | 22,957 | 17.10 | 392,564 |
| 2026-08-10 | Ricci Gabriele (Chief Data & Tech. Officer) | Sale | 25,088 | 17.10 | 429,004 |
| 2026-08-10 | Duprey Lauren Rusckowski (Chief Transformation Officer) | Sale | 47,586 | 17.10 | 813,720 |
| 2026-08-10 | Kim Julie So-young (President and CEO) | Sale | 89,090 | 17.10 | 1,523,439 |
| 2026-08-10 | Plump Andrew Stewart (President, R&D) | Sale | 165,393 | 17.10 | 2,828,220 |
| 2026-08-10 | Platford Giles Richard (President, IBU) | Sale | 31,083 | 17.10 | 531,519 |
| 2026-08-10 | Bitetti Teresa Marie (President, OBU) | Sale | 50,012 | 17.10 | 855,205 |
Insider trading activities including stock purchases, stock sales, and option exercises of TAK listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Takeda Pharmaceutical Co Ltd (symbol TAK, CIK number 1395064) see the Securities and Exchange Commission (SEC) website.